McGinn OJ, Krishnan S, Bourquin J-P, Sapra P, Dempsey C, Saha V, Stern PL. Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia. Haematologica [Internet]. 2017May31 [cited 2026Nov.3];102(6):1075-84. Available from: https://haematologica.org/article/view/8098